CASP3 and neoplasm: In vivo, a multi‐dose study with 10 min FUS exposure shows that 0 and 4‐h intervals between TRAIL and FUS significantly reduce tumor burden, with an increase in apoptosis evident by enhanced cleaved‐caspase 3 expression.